Compare Teradyne, Inc. (TER) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Teradyne, Inc. vs UnitedHealth Group Inc — how do they compare? Teradyne, Inc. trades at $377 (market cap $59.99B), while UnitedHealth Group Inc trades at $394.3 (market cap $352.81B). The key difference: UnitedHealth Group Inc is far larger — about 5.9× Teradyne, Inc.'s market cap, and UnitedHealth Group Inc pays the higher dividend (2.36%). Which is the better fit depends on your goals.
| TER | UNH | |
|---|---|---|
Market Cap | $59.99B | $352.81B |
Sector | Technology | Health |
52-Week High | $483.84 | $436.35 |
52-Week Low | $112.24 | $259.02 |
Enterprise Value | $59.73B | $394.67B |
Dividend Yield | 0.14% | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Teradyne (TER) trades at $372.06, up 4.21% in the last session, with a bullish technical signal and strong institutional interest. The stock shows robust fundamentals, including a 59.24% gross margin and consistent earnings beats, with Q3 2026 EPS expected at $2.03. Recent news highlights AI-driven demand for UltraFLEXplus systems, positioning TER for growth in semiconductor testing.
Outlook is positive with a $474.78 analyst price target implying 28% upside, supported by AI and data center expansion. Risks include reliance on tech cycles and competitive pressures from KLA and Cohu. Cash flow trends show improvement, with net cash flow projected to turn positive in 2026.
UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
